{"id":"mometasone-furoate-as-a-nasal-spray","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Pharyngitis"},{"rate":null,"effect":"Epistaxis"},{"rate":null,"effect":"Nasal irritation"}]},"_chembl":{"chemblId":"CHEMBL1161","moleculeType":"Small molecule","molecularWeight":"521.44"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Mometasone furoate binds to glucocorticoid receptors in nasal tissue, inhibiting the production of pro-inflammatory cytokines and mediators. This reduces nasal inflammation, congestion, and associated symptoms in allergic and non-allergic rhinitis. The nasal spray formulation delivers the drug directly to the site of inflammation with minimal systemic absorption.","oneSentence":"Mometasone furoate is a corticosteroid that reduces inflammation in the nasal passages by suppressing immune and inflammatory responses.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:50:06.409Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Allergic rhinitis"},{"name":"Nasal polyps"},{"name":"Non-allergic rhinitis"}]},"trialDetails":[{"nctId":"NCT06451640","phase":"PHASE2","title":"A Extension Clinical Study of TQC2731 Injection in the Treatment of Chronic Sinusitis With Nasal Polyps","status":"COMPLETED","sponsor":"Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.","startDate":"2024-07-04","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":59},{"nctId":"NCT06013241","phase":"PHASE2","title":"A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)","status":"COMPLETED","sponsor":"Insmed Incorporated","startDate":"2023-10-30","conditions":"Chronic Rhinosinusitis Without Nasal Polyps","enrollment":288},{"nctId":"NCT05382494","phase":"PHASE4","title":"Intranasal Steroid as Medical Therapy For Sleep-Disordered Breathing in Children","status":"COMPLETED","sponsor":"Murdoch Childrens Research Institute","startDate":"2022-12-05","conditions":"Sleep Disorder; Breathing-Related, Snoring, Obstructive Sleep Apnea of Child","enrollment":130},{"nctId":"NCT07174115","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety of HTMC0658 Tablets in the Treatment of Chronic Rhinosinusitis Without Nasal Polyps","status":"RECRUITING","sponsor":"Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.","startDate":"2025-08-18","conditions":"Chronic Sinusitis Without Nasal Polyps","enrollment":30},{"nctId":"NCT07114107","phase":"NA","title":"Vibroacoustic Therapy With Oscillating Positive Expiratory Pressure in the Treatment of Nasal Congestion","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-08","conditions":"Atopic Rhinitis, Atopic Asthma","enrollment":200},{"nctId":"NCT06036927","phase":"PHASE2","title":"A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal Polyps","status":"COMPLETED","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2023-12-08","conditions":"Chronic Sinusitis, Nasal Polyps","enrollment":80},{"nctId":"NCT00779740","phase":"PHASE3","title":"Equivalency Study of Two Formulations of Mometasone Furoate Nasal Spray (Study P04419)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-02-01","conditions":"Rhinitis, Allergic, Perennial","enrollment":102},{"nctId":"NCT00750750","phase":"PHASE2","title":"Effectiveness and Safety of Once or Twice Daily Mometasone Nasal Spray Versus Amoxicillin Versus Placebo for Treatment of Acute Rhinosinusitis (Study P02683)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-01-01","conditions":"Acute Rhinosinusitis","enrollment":981},{"nctId":"NCT00751075","phase":"PHASE3","title":"Effectiveness and Safety of Once or Twice Daily Mometasone Nasal Spray Versus Amoxicillin Versus Placebo for Treatment of Acute Rhinosinusitis (Phase 3 Study)(Study P02692)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-12-01","conditions":"Acute Rhinosinusitis","enrollment":981},{"nctId":"NCT01165424","phase":"PHASE3","title":"A Study of Long-term Administration of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06333AM1)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2010-04","conditions":"Rhinitis, Allergic, Perennial","enrollment":80},{"nctId":"NCT01386125","phase":"PHASE3","title":"A Study of the Effectiveness and Safety of Mometasone Furoate Nasal Spray (MFNS, SCH 032088) for the Treatment of Nasal Polyps (P05604)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2011-06","conditions":"Nasal Polyps","enrollment":748},{"nctId":"NCT06200766","phase":"PHASE3","title":"A Multicenter, Randomized, Double-blind, Three-arm, Parallel Clinical Endpoint Bioequivalence Study of Monometasone Furoate Nasal Spray in Patients With Seasonal Allergic Rhinitis","status":"UNKNOWN","sponsor":"Zheng Liu ENT","startDate":"2023-08-25","conditions":"Seasonal Allergic Rhinitis","enrollment":640},{"nctId":"NCT05590598","phase":"PHASE3","title":"Efficacy and Safety of Azelastine +Mometasone , Nasal Spray, 140 mcg + 50 mcg, (Sandoz d.d., Slovenia) and Momat Rino Advance, Nasal Spray, 140 mcg + 50 mcg, (Glenmark, India) Administered as a Monotherapy to Patients With Seasonal Allergic Rhinitis.","status":"COMPLETED","sponsor":"Sandoz","startDate":"2023-02-13","conditions":"Seasonal Allergic Rhinitis","enrollment":472},{"nctId":"NCT03688555","phase":"PHASE2","title":"A Study to Evaluate the Effect of ACT-774312 in Subjects With Bilateral Nasal Polyposis","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2018-10-19","conditions":"Bilateral Nasal Polyposis","enrollment":10},{"nctId":"NCT05301647","phase":"","title":"Mometasone Furoate Nasal Spray in Italian Children","status":"COMPLETED","sponsor":"University of Campania Luigi Vanvitelli","startDate":"2019-06-20","conditions":"Rhinitis, Allergic, Nasal Allergy, Allergy Pollen","enrollment":80},{"nctId":"NCT03855228","phase":"PHASE3","title":"Safety and Efficacy of Mometasone Furoate Nasal Spray With the Addition of Loratadine Versus Placebo in Participants With Seasonal Allergic Rhinitis (C94-145)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"1995-03-01","conditions":"Rhinitis, Allergic","enrollment":704},{"nctId":"NCT03085797","phase":"PHASE3","title":"Effect of Mepolizumab in Severe Bilateral Nasal Polyps","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2017-05-25","conditions":"Nasal Polyps","enrollment":414},{"nctId":"NCT02318303","phase":"PHASE2","title":"To Study GSP 301 in Patients With Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Glenmark Pharmaceuticals Ltd. India","startDate":"2014-12","conditions":"Seasonal Allergic Rhinitis","enrollment":1111},{"nctId":"NCT03280550","phase":"PHASE3","title":"A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2017-11-15","conditions":"Nasal Polyps, Chronic Rhinosinusitis","enrollment":138},{"nctId":"NCT03280537","phase":"PHASE3","title":"A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitus With Nasal Polyps","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2017-11-21","conditions":"Nasal Polyps, Chronic Rhinosinusitis","enrollment":127},{"nctId":"NCT03444506","phase":"PHASE2","title":"Efficacy and Safety of Fixed Dose Combination (FDC) of Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Molo; Also Referred as GSP 301) in the Treatment of Seasonal Allergic Rhinitis (SAR)","status":"COMPLETED","sponsor":"Glenmark Pharmaceuticals Ltd. India","startDate":"2014-01-27","conditions":"Seasonal Allergic Rhinitis","enrollment":180},{"nctId":"NCT02397915","phase":"PHASE4","title":"Patient Preference Study of Fluticasone Furoate and Mometasone Furoate Nasal Sprays","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2015-03-26","conditions":"Rhinitis, Allergic, Perennial and Seasonal","enrollment":300},{"nctId":"NCT01700192","phase":"PHASE3","title":"Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2013-01","conditions":"Rhinitis, Allergic, Perennial, Rhinitis, Allergic, Nonseasonal","enrollment":1482},{"nctId":"NCT01920893","phase":"PHASE2","title":"An Evaluation of Dupilumab in Patients With Nasal Polyposis And Chronic Symptoms Of Sinusitis","status":"COMPLETED","sponsor":"Sanofi","startDate":"2013-08","conditions":"Nasal Polyps","enrollment":60},{"nctId":"NCT00562159","phase":"PHASE3","title":"Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2007-11","conditions":"Rhinoconjunctivitis, Rhinitis, Conjunctivitis","enrollment":439},{"nctId":"NCT00550550","phase":"PHASE3","title":"Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2007-11","conditions":"Rhinoconjunctivitis, Rhinitis, Conjunctivitis","enrollment":345},{"nctId":"NCT01861145","phase":"PHASE4","title":"Intranasal Steroids for the Treatment of Nocturnal Enuresis With Associated Obstructive Sleep Apnea","status":"WITHDRAWN","sponsor":"University of Alberta","startDate":"2013-05","conditions":"Enuresis, Obstructive Sleep Apnea, Sleep Disordered Breathing","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Mometasone furoate as a nasal spray","genericName":"Mometasone furoate as a nasal spray","companyName":"Zheng Liu ENT","companyId":"zheng-liu-ent","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Mometasone furoate is a corticosteroid that reduces inflammation in the nasal passages by suppressing immune and inflammatory responses. Used for Allergic rhinitis, Nasal polyps, Non-allergic rhinitis.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}